Liheng Guo
Overview
Explore the profile of Liheng Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen M, Wang F, Huang L, Qi T, Guo H, Zeng R, et al.
BMC Complement Med Ther
. 2024 Sep;
24(1):330.
PMID: 39243078
Background: For patients with sepsis receiving non-invasive ventilation (NIV), early rehabilitation is crucial. The Sitting Baduanjin (SBE) is an efficient early rehabilitation exercise suitable for bed patients. There is no...
2.
Zhu J, Dong Y, Liao P, Yin X, He J, Guo L
Heart Lung
. 2023 Dec;
64:93-99.
PMID: 38070279
Background: Sepsis patients have a high mortality rate and are frequently anemic. The importance of early detection and blood transfusion treatment cannot be overstated. Objective: A systematic review and meta-analysis...
3.
Zeng R, Zhang Y, Xu J, Kong Y, Tan J, Guo L, et al.
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048698
Both low and high glycated hemoglobin A1c (HbA1c) levels are well-established causal risk factors for all-cause and cardiovascular mortality in the general population and diabetic patients. However, the relationship between...
4.
Li X, Huang F, Zhu L, Luo T, Zhang Y, Gu H, et al.
Front Pharmacol
. 2022 Nov;
13:1041326.
PMID: 36438846
Septic shock has increasingly become a cause of death threatening human survival. Shenfu Injection (SFI), a patented Chinese medicine, has been widely used in the treatment of patients with sepsis...
5.
Su Y, Yin X, Huang X, Guo Q, Ma M, Guo L
Life Sci
. 2022 Oct;
310:121123.
PMID: 36302499
Aims: Sepsis can induce multiple organ dysfunction, and sepsis-induced myocardial dysfunction (SIMD) is relatively common. The current dilemma might ascribe partly to SIMD's lack of unified molecular mechanisms. Our study...
6.
Su Y, Yin X, Huang X, Guo Q, Ma M, Guo L
Pharm Biol
. 2022 Sep;
60(1):1812-1818.
PMID: 36121248
Context: Astragaloside IV (AS-IV) is extracted from (Fisch.) Bunge (Fabaceae). However, its effects on endothelial cell injury remain unclear. Objective: To investigate the mechanisms underlying the effects of AS-IV on...
7.
Lian B, Zeng R, Chen Y, Liao P, Guo L, Zhang M
J Tradit Chin Med
. 2021 Feb;
41(1):26-35.
PMID: 33522194
Objective: To investigate the efficacy and safety of Sodium tanshinone ⅡA sulfonate (STS) plus the conventional treatment on acute myocardial infarction (AMI) patients. Methods: We searched several electrical databases and...
8.
Mao S, Wang L, Zhao X, Guo L, Lin Q, Wang X, et al.
Cardiovasc Drugs Ther
. 2020 Sep;
35(2):321-329.
PMID: 32940893
Background: Sodium tanshinone IIA sulfonate (STS) has been widely used by Chinese medicine practitioners for chronic cardiovascular diseases. However, its direct clinical efficacy in patients with acute coronary syndrome following...
9.
Mao S, Zhang X, Chen M, Wang C, Chen Q, Guo L, et al.
Cardiovasc Drugs Ther
. 2020 Aug;
35(1):21-32.
PMID: 32761487
Background: The beneficial effects of physical exercise on cardiac remodelling improvement after myocardial infarction have already been suggested. However, the results of previous clinical trials have not been consistent. Moreover,...
10.
Pan W, Lian B, Lu H, Liao P, Guo L, Zhang M
Biomed Res Int
. 2020 Jul;
2020:6960107.
PMID: 32714983
Objective: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthesis, is reported to be a risk factor for cardiovascular disease. The purpose of the present study is to...